Diversity in Clinical Trial Enrollment in Key...

Dr. Fumiko Chino talks with Dr. Evan Garrad, the first author of the JCO OP manuscript, "Artificial Intelligence Among US Hematology-Oncology Fellows: A Multicenter Survey of Education, Attitudes, and Clinical Use," which was simultaneously published with his oral presentation at ...  Show more

Dr. Chino welcomes Dr. Christopher Manz, a medical oncologist at Dana-Farber Cancer Institute, to discuss new research highlighting care gaps for those receiving care while in prison. Dr. Manz investigates cancer care delivery and payment policy and how they contribute to dispari ...  Show more

What does the cutting edge of radiation oncology look like for treating triple-negative breast cancer? Tune in to hear experts Drs Kevin Kalinsky and Reshma Jagsi discuss. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarti ...  Show more

Join Drs Kevin Kalinsky and Jennifer Litton as they discuss hereditary breast cancer, genetic testing, and therapeutic implications. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991258). The topics and discussions ...  Show more

<span style= "font-size: 12pt; line-height: 107%; font-family: arial, helvetica, sans-serif;"> Drs. John Sweetenham and Lawrence Shulman discuss the challenges that oncologists will be confronting in 2024 and share insights on how to build clinician resilience and optimize the ...

Join experts Drs Kevin Kalinsky and Priyanka Sharma as they discuss their current approach to neoadjuvant therapy in triple negative breast cancer and how the SCARLET trial might change that. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.m ...  Show more